Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
At the new centre, customers get a real-time experience of the process of genetic testing and actionable plans in preventive healthcare under the expertise of certified genetic counsellors
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
The centre established by Nucleome Informatics will take up the sequencing of 5,000 Covid genomes and 500 human genomes in the coming months
Healthcare speed-scaling platform offers clinical validation, regulatory support, mentorship, and investor access to startups working across preventive health, oncology, genomics, diagnostics, and digital health
From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
